Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 family

References

• WynnGHOesterheldJRCozzaKArmstrongSCClinical Manual of Drug Interaction Principles for Medical PracticeArlington, VAAmerican Psychiatric Publishing2009
   Google Scholar
• LicinioJWongMLThe pharmacogenomics of depressionPharmacogenomics J200113175177 Review11908753
   PubMedGoogle Scholar
• BertilssonIDahlM-LTybringGPharmacogenetics of antidepressants: clinical aspectsActa Psychiatr Scand Suppl19973911421 Review9265947
   PubMedGoogle Scholar
• The Human Cytochrome P450 (CYP) Allele Nomenclature Committee [homepage on the Internet]StockholmKarolinska group [updated 2008 Sep]. Available from: http://www.cypalleles.ki.se. Accessed May 23, 2011
   Google Scholar
• Ingelman-SundbergMSimSCPharmacogenetic biomarkers as tools for improved drug therapy; emphasis on the cytochrome P450 systemBiochem Biophys Res Commun521201039619094 Review20494117
   PubMed Web of Science ®Google Scholar
• de LeonJArmstrongSCCozzaKLClinical guidelines for using pharmacogenetic testing of CYP450 2D6 and CYP450 2C19 in psychiatryPsychosomatics200647758516384813
   PubMed Web of Science ®Google Scholar
• ZourkováAHadasováEParoxetine-induced conversion of cytochrome P450 2D6 phenotype and occurence of adverse effectsGen Physiol Biophys20032210311312870705
   PubMed Web of Science ®Google Scholar
• GascheYDaaliYFathiMCodeine intoxication associated with ultrarapid CYP2D6 metabolismN Engl J Med20043512827283115625333
   PubMed Web of Science ®Google Scholar
• ZackrissonALLindblomBAhlnerJHigh frequency of occurrence of CYP2D6 gene duplication/multiduplication indicating ultrarapid metabolism among suicide casesClin Pharmacol Ther201088335435919907421
   PubMed Web of Science ®Google Scholar
• ZackrissonALHolmgrenPGladhABAhlnerJLindblomBFatal intoxication cases: cytochrome P450 2D6 and 2C19 genotype distributionsEur J Clin Pharmacol200460854755215349706
   PubMed Web of Science ®Google Scholar
• ZackrissonALHolmgrenPGladhABAhlnerJLindblomBCytochrome P450 2D6 genotyping of fatal intoxications using PyrosequencingProgress in Forensic Genetics 10200412613638
   Google Scholar
• SimSCRisingerCDahlMLA common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors andantidepressantsClin Pharmacol Ther200679110311316413245
   PubMed Web of Science ®Google Scholar
• SachdevPThe epidemiology of drug-induced akathisia: part I. Acute akathisiaSchizophr Bull1995213431449 Review7481574
   PubMed Web of Science ®Google Scholar
• SachdevPThe epidemiology of drug-induced akathisia: part II. Chronic, tardive, and withdrawal akathisiasSchizophr Bull1995213451461 Review7481575
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration (FDA) Drugs@FDAFDA approved drug products [webpage on the Internet]Silver Spring, MDFDA [nd]. Available from: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm. Accessed April 28, 2011
   Google Scholar
• VandelPHaffenEVandelSDrug extrapyramidal side effects. CYP2D6 genotypes and phenotypesEur J Clin Pharmacol199955965966510638395
   PubMed Web of Science ®Google Scholar
• Indiana University School of Medicine Department of Medicine, Division of Clinical Pharmacology. Drug Interactions: cytochrome P450 drug interaction table [website on the Internet]Indianapolis, INIndiana University School of Medicine2011 [updated April 12, 2011]. Available from: http://medicine.iupui.edu/clinpharm/ddis/table.asp Accessed April 12, 2011
   Google Scholar
• BaumannPHiemkeCUlrichSThe AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatryPharmacopsychiatry200437624326515551191
   PubMed Web of Science ®Google Scholar
• BregginPRSuicidality, violence and mania caused by selective serotonin reuptake inhibitors (SSRIs): a review and analysisInt J Risk Saf Med20031613149
   Google Scholar
• LargeMSharmaSComptonMTSladeTNielssenOCannabis use and earlier onset of psychosis: a systematic meta-analysisArch Gen Psychiatry Epub February 7, 2011
   Google Scholar
• PiatkovIJonesTRochesterCCytochrome P450 loss-of-function polymorphism genotyping on the Agilent Bioanalyzer and clinical applicationPharmacogenomics200910121987199419958097
   PubMed Web of Science ®Google Scholar
• Pers comm; Keith Byron, 2011
   Google Scholar
• GaedigkASimonSDPearceREBradfordLDKennedyMJLeederJSThe CYP2D6 activity score: translating genotype information into a qualitative measure of phenotypeClin Pharmacol Ther200883223424217971818
   PubMed Web of Science ®Google Scholar
• SjöqvistFAlexandersonBAsbergMPharmacokinetics and biological effects of nortriptyline in manActa Pharmacol Toxicol (Copenh)197129Suppl 32552805316407
   PubMedGoogle Scholar
• BertilssonLEichelbaumMMellströmBSäweJSchulzHUSjöqvistFNortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in manLife Sci19802718167316777442467
   PubMed Web of Science ®Google Scholar
• MellströmBBertilssonLSäweJSchulzHUSjöqvistFE- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylationClin Pharmacol Ther19813021891937249504
   PubMed Web of Science ®Google Scholar
• von BahrCBirgerssonCBlanckAGöranssonMMellströmBNilsellKCorrelation between nortriptyline and debrisoquine hydroxylation in the human liverLife Sci19833376316366410141
   PubMed Web of Science ®Google Scholar
• DahlMLNordinCBertilssonLEnantioselective hydroxylation of nortriptyline in human liver microsomes, intestinal homogenate, and patients treated with nortriptylineTher Drug Monit19911331891941926270
   PubMed Web of Science ®Google Scholar
• KinNMKlitgaardNNairNPClinical relevance of serum nortriptyline and 10-hydroxy-nortriptyline measurements in the depressed elderly: a multicenter pharmacokinetic and pharmacodynamic studyNeuro Psychopharmacology199615116
   Google Scholar
• PerryPJZeilmannCArndtSTricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of responseJ Clin Psychopharmacol1994144230240 Review7962678
   PubMed Web of Science ®Google Scholar
• SteimerWZöpfKvon AmelunxenSAmitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapyClin Chem200551237638515590749
   PubMed Web of Science ®Google Scholar
• VenkatakrishnanKvon MoltkeLLGreenblattDJNortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugsJ Clin Pharmacol1999396567577 Erratum in: J Clin Pharmacol. 1999;39(8):86610354960
   PubMed Web of Science ®Google Scholar
• BrøsenKKragh-SørensenPConcomitant intake of nortriptyline and carbamazepineTher Drug Monit19931532582608333008
   PubMed Web of Science ®Google Scholar
• KrähenbühlSSmith-GambleVHoppelCLPharmacokinetic interaction between diltiazem and nortriptylineEur J Clin Pharmacol19964954174198866640
   PubMed Web of Science ®Google Scholar
• GannonRHAndersonMLFluconazole-nortriptyline drug interactionAnn Pharmacother19922611145614571477454
   PubMed Web of Science ®Google Scholar
• BebchukJMStewartDEDrug interaction between rifampin and nortriptyline: a case reportInt J Psychiatry Med19912121831871894457
   PubMed Web of Science ®Google Scholar
• ZhouSGaoYJiangWHuangMXuAPaxtonJWInteractions of herbs with cytochrome P450Drug Metab Rev2003351359812635815
   PubMed Web of Science ®Google Scholar
• LefebvreTFosterBCDrouinCEKrantisALiveseyJFJordanSAIn vitro activity of commercial valerian root extracts against human cytochrome P450 3A4J Pharm Pharm Sci200412 7(2)26527315367385
   PubMed Web of Science ®Google Scholar
• DonovanJLDeVaneCLChavinKDMultiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteersDrug Metab Dispos200432121333133615328251
   PubMed Web of Science ®Google Scholar
• ArmstrongSCCozzaKLSandsonNBSix Patterns of drug-drug interactionsPsychosomatics200344325525812724509
   PubMed Web of Science ®Google Scholar
• SpinaESantoroVD’ArrigoCClinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an updateClin Ther200830712061227 Review18691982
   PubMed Web of Science ®Google Scholar
• MargolisJMO’DonnellJPMankowskiDCEkinsSObachRS(R)-, (S)-, and racemic fluoxetine N-demethylation by human cytochrome P450 enzymesDrug Metab Dispos200028101187119110997938
   PubMed Web of Science ®Google Scholar
• ScordoMGSpinaEDahlMLGattiGPeruccaEInfluence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetineBas Clin Pharmacol Toxicol2005975296301
   PubMed Web of Science ®Google Scholar
• RingBJEcksteinJAGillespieJSBinkleySNVandenBrandenMWrightonSAIdentification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetineJ Pharmacol Exp Ther200129731044105011356927
   PubMed Web of Science ®Google Scholar
• FjordsideLJeppesenUEapCBPowellKBaumannPBrøsenKThestereoselective metabolism of fluoxetine in poor and extensive metabolizers of sparteinePharmacogenetics199991556010208643
   PubMedGoogle Scholar
• YamaoriSEbisawaJOkushimaYYamamotoIWatanabeKPotent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moietyLife Sci201111 88(15–16)730736 Epub February 26, 201121356216
   PubMed Web of Science ®Google Scholar
• Sachse-SeebothCPfeilJSehrtDInterindividual variation in the pharmacokinetics of Delta9-tetrahydrocannabinol as related to genetic polymorphisms in CYP2C9Clin Pharmacol Ther2009853273276 Epub November 12, 200819005461
   PubMed Web of Science ®Google Scholar
• WatanabeKYamaoriSFunahashiTKimuraTYamamotoICytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomesLife Sci200720801514151419 Epub January 17, 200717303175
   PubMed Web of Science ®Google Scholar
• BlandTMHainingRLTracyTSCalleryPSCYP2C-catalyzed delta9-tetrahydrocannabinol metabolism: kinetics, pharmacogenetics and interaction with phenytoinBiochem Pharmacol20051 70(7)1096110316112652
   PubMed Web of Science ®Google Scholar
• Eli Lilly and CoProzac Weekly^® [product information]IndianapolisEli Lilly and Co2001 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-235_Prozac_Prntlbl.pdf. Accessed June 13, 2011
   Google Scholar
• SawamuraKSuzukiYSomeyaTEffects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetineEur J Clin Pharmacol2004608553557 Epub September 3, 200415349705
   PubMed Web of Science ®Google Scholar
• CharlierCBrolyFLhermitteMPintoEAnsseauMPlomteuxGPolymorphisms in the CYP 2D6 gene: association with plasma concentrations of fluoxetine and paroxetineTher Drug Monit200325673874214639062
   PubMed Web of Science ®Google Scholar
• SindrupSHBrøsenKGramLFThe relationship between paroxetine and the sparteine oxidation polymorphismClin Pharmacol Ther19925132782871531950
   PubMed Web of Science ®Google Scholar
• JeppesenUGramLFVistisenKLoftSPoulsenHEBrøsenKDose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetineEur J Clin Pharmacol199651173788880055
   PubMed Web of Science ®Google Scholar
• SindrupSHBrøsenKGramLFPharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: nonlinearity and relation to the sparteine oxidation polymorphismClin Pharmacol Ther19925132882951531951
   PubMed Web of Science ®Google Scholar
• BregginPRIntoxication anosognosia: the spellbinding effect of psychiatric drugsEthical Hum Psychol Psychiatry200683201205
   Google Scholar
• RudbergIHermannMRefsumHMoldenESerum concentrations of sertraline and N-desmethyl sertraline in relation to CYP2C19 genotype in psychiatric patientsEur J Clin Pharmacol2008641211811188 Epub August 3, 200818677622
   PubMed Web of Science ®Google Scholar
• GunesABilirEZengilHBabaogluMOBozkurtAYasarUInhibitory effect of valproic acid on cytochrome P450 2C9 activity in epilepsy patientsBas Clin Pharmacol Toxicol20071006383386
   PubMed Web of Science ®Google Scholar
• Wyeth Pharmaceuticals IncEffexor XR^® [product information]Philadelphia, PAWyeth Pharmaceuticals Inc2005 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020699s054,057lbl.pdf. Accessed June 13, 2011
   Google Scholar
• HermannMHendsetMFosaasKHjerpsetMRefsumHSerum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 alleleEur J Clin Pharmacol2008645483487 Epub January 23, 200818214456
   PubMed Web of Science ®Google Scholar
• ShamsMEArnethBHiemkeCCYP2D6 polymorphism and clinical effect of the antidepressant venlafaxineJ Clin Pharmacol Ther2006315493502
   PubMed Web of Science ®Google Scholar
• FukudaTNishidaYZhouQYamamotoIKondoSAzumaJThe impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese populationEur J Clin Pharmacol200056217518010877013
   PubMed Web of Science ®Google Scholar
• LindhJDAnnasAMeurlingLDahlMLAL-ShurbajiAEffect of ketoconazole on venlafaxine plasma concentrations in extensive and poor metabolisers of debrisoquineEur J Clin Pharmacol2003595–6401406 Epub July 25, 200312898080
   PubMed Web of Science ®Google Scholar
• FogelmanSMSchmiderJVenkatakrishnanKO- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressantsNeuro psychopharmacology1999205480490
   Web of Science ®Google Scholar
• SriwiriyajanSSamaengMRidtitidWMahatthanatrakulWWongnawaMPharmacokinetic interactions between ciprofloxacin and itraconazole in healthy male volunteersBiopharm Drug Dis2011323168174 Epub March 1, 2011.
   PubMed Web of Science ®Google Scholar
• ShahzadiAJavedIAslamBTherapeutic effects of ciprofloxacin on the pharmacokinetics of carbamazepine in healthy adult male volunteersPak J Pharm Sci2011241636821190921
   PubMed Web of Science ®Google Scholar
• ElkoCJBurgessJLRobertsonWOZolpidem-associated hallucinations and serotonin reuptake inhibition: a possible interactionJ Toxicol Clin Toxicol1998363195203 Review9656974
   PubMed Web of Science ®Google Scholar
• VlaseLPopaANeagMMunteanDLeucutaSEPharmacokinetic interaction between zolpidem and ciprofloxacin in healthy volunteersEur J Drug Metab Pharmacokinet2011353–48387 Epub October 5, 2010.21302033
   PubMed Web of Science ®Google Scholar
• OwensMJKnightDLNemeroffCBSecond-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetineEur J Drug Metab Pharmacokinet2001505345350
   Google Scholar
• OlesenOVLinnetKStudies on the stereoselective metabolism of citalopram by human liver microsomes and cDNA-expressed cytochrome P450 enzymesPharmacology199959629830910575324
   PubMed Web of Science ®Google Scholar
• HerrlinKYasui-FurukoriNTybringGWidénJGustafssonLLBertilssonLMetabolism of citalopram enantiomers in CYP2C19/CYP2D6 phenotyped panels of healthy SwedesBritish J Clin Pharmacol2003564415421
   PubMed Web of Science ®Google Scholar
• von MoltkeLLGreenblattDJGiancarloGMGrandaBWHarmatzJSShaderRIEscitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopramDrug Metab Dispos20012981102110911454728
   PubMed Web of Science ®Google Scholar
• MannelMDrug interactions with St John’s wort: mechanisms and clinical implicationsDrug Saf20042711773797 Review15350151
   PubMed Web of Science ®Google Scholar
• RobinsonDSSerotonin SyndromePrimary Psychiatry20061383638
   Google Scholar
• FukudaTYamamotoINishidaYEffect of the CYP2D6*10 genotype on venlafaxine pharmacokinetics in healthy adult volunteersBr J Clin Pharmacol199947445045310233212
   PubMed Web of Science ®Google Scholar
• FukudaTNishidaYZhouQYamamotoIKondoSAzumaJThe impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese populationEur J Clin Pharmacol20005562:1758010877013
   PubMed Web of Science ®Google Scholar
• VeefkindAHHaffmansPMHoencampEVenlafaxine serum levels and CYP2D6 genotypeTher Drug Monit200022220220810774634
   PubMed Web of Science ®Google Scholar
• SafeekhATPintoDVenlafaxine-induced psychotic symptomsIndian J Psychiatry200951430830920048460
   PubMedGoogle Scholar
• PfefferFGrubeMAn organic psychosis due to a venlafaxine-propafenone interactionInt J Psychiatry Med200131442743211949740
   PubMed Web of Science ®Google Scholar
• GareriPDe FazioPGallelliLVenlafaxine-propafenone interaction resulting in hallucinations and psychomotor agitationAnn Pharmacother3200842343443818303146
   PubMed Web of Science ®Google Scholar
• HoweCRavasiaSVenlafaxine-induced deliriumCan J Psychiatry200348212912655917
   PubMed Web of Science ®Google Scholar
• AlexanderJNillsenAVenlafaxine-induced deliriumAus NZJ Psychiatry Epub March 24, 2011
   Google Scholar
• Wyeth Australia Pty LtdEfexor^®-XR [product information]Baulkham Hills, NSWWyeth Australia Pty Ltd2010
   Google Scholar
• RochatBAmeyMGilletMMeyerUABaumannPIdentification of three cytochrome P450 isozymes involved in N-demethylation of citalopram enantiomers in human liver microsomesPharmacogenetics1997711109110356
   PubMedGoogle Scholar
• YuBNChenGLHeNPharmacokinetics of citalopram in relation to genetic polymorphism of CYP2C19Drug Metab Dispos200331101255125912975335
   PubMed Web of Science ®Google Scholar
• PedersenRSDamkierPBrosenKTramadol as a new probe for cytochrome P450 2D6 phenotyping: a population studyClin Pharmacol Ther200577645846715961977
   PubMed Web of Science ®Google Scholar
• TangCShouMRushmoreTHIn-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokineticsPharmacogenetics200111322323511337938
   PubMedGoogle Scholar
• WernerUWernerDRauTFrommMFHinzBBruneKCelecoxib inhibits metabolism of cytochrome P450 2D6 substrate metoprolol in humansClin Pharmacol Ther200374213013712891223
   PubMed Web of Science ®Google Scholar
• HalbergPKarlssonJKurlandLThe CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trialJ Hypertens200220102089209312359989
   PubMed Web of Science ®Google Scholar
• ChamSEvansMADenenbergJOGolombBAStatin-associated muscle-related adverse effects: a case series of 354 patientsPharmacotherapy201030654155320500044
   PubMed Web of Science ®Google Scholar
• Li-Wan-PoAGirardTFarndonPCooleyCLithgowJPharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17Br J Clin Pharmacol2010693222230 Review20233192
   PubMed Web of Science ®Google Scholar
• HealyDLet them eat prozac: the unhealthy relationship between the pharmaceutical industry and depressionNew YorkNew York University Press2004
   Google Scholar
• HealyDThe trials. Let them eat Prozac [website on the Internet] [Nd.] Available from: http://www.healyprozac.com/Trials/default.htm. Accessed July 1, 2011
   Google Scholar
• HealyDLines of evidence on the risks of suicide with selective serotonin reuptake inhibitorsPsychother Psychosom20037227179 Review12601224
   PubMed Web of Science ®Google Scholar
• LaughrenTPMemorandum: overview for December 13 meeting of Psychopharmacologic Drugs Advisory Committee (PDAC)Silver Spring, MDUS Department of Health and Human Services, Public Health Service, Food and Drug Administration Center for Drug Evaluation and Research2006 Available from: http://www.fda.gov/ohrms/DOCKETS/ac/06/briefing/2006-4272b1-01-FDA.pdf. Accessed April 12, 2011.
   Google Scholar
• FDAAntidepressant use in children, adolescents, and adultsUS Food and Drug Administration [website on the Internet]Silver Spring, MDFDA [updated Aug 12, 2010]. Available from: http://www.fda.gov/drugs/drugsafety/informationbydrugclass/ucm096273.htm. Accessed April 12, 2011
   Google Scholar
• HealyDHarrisRTranterRLifetime suicide rates in treated schizophrenia: 1875–1924 and 1994–1998 cohorts comparedBr J Psychiatry200618822322816507962
   PubMed Web of Science ®Google Scholar
• LawrenceDJablenskyAVHolmanCDPinderTJMortality in Western Australian psychiatric patientsSoc Psychiatry Psychiatr Epidemiol200035834134711037302
   PubMed Web of Science ®Google Scholar
• SahaSChantDMcGrathJA systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?Arch Gen Psychiatry200764101123111317909124
   PubMed Web of Science ®Google Scholar
• ColtonCWManderscheidRWCongruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight statesPre Chronic Dis200632A42
   PubMedGoogle Scholar
• BurgessPPirkisJJolleyDWhitefordHSaxenaSDo nations’ mental health policies, programs and legislation influence their suicide rates? An ecological study of 100 countriesAus N Z J Psychiatry20043811–12933939
   PubMed Web of Science ®Google Scholar
• New South Wales (NSW) Mental Health Sentinel Events Review CommitteeTracking Tragedy: a systemic look at homicide and non-fatal serious injury by mental health patients, and suicide death of mental health inpatients. Fourth Report of the Committee New South Wales: NSW Mental Health Sentinel Events Review Committee; March 2008. [Updated and confirmed by question 10218 in NSW parliament.] Available from: http://www.health.nsw.gov.au/pubs/2009/pdf/tracking_tragedy_2008_fourth_report.PDF. Accessed April 12, 2011
   Google Scholar
• American Psychiatric AssociationSchizophrenia and other psychotic disorders and Mood DisordersDiagnostic and statistical manual of mental disorders (DSM IV)4th edWashington DCAmerican Psychiatric Association1994273391
   Google Scholar
• Australian Bureau of StatisticsNational Health Survey: Mental Health, Australia, 2001CanberraAustralian Bureau of Statistics [updated December 8, 2006]. Available from: http://www.abs.gov.au/ausstats/[email protected]/mf/4811.0 Accessed June 9, 2011
   Google Scholar
• OlfsonMMarcusSCNational patterns in antidepressant medication treatmentArch Gen Psychiatry200966884885619652124
   PubMed Web of Science ®Google Scholar
• NanayakkaraPWMeijboomMSchoutenJASuicidal and aggressive thoughts as a result of taking a Hypericum preparation (St John’s wort)Ned Tijdschr Geneeskd2005611149241347134916008039
   PubMedGoogle Scholar
• MarksDHBregginPRBraslowDHomicidal ideation causally related to therapeutic medicationsInt J Risk Saf Med2008204231240
   Google Scholar
• MooreTJGlenmullenJFurbergCDPrescription drugs associated with reports of violence towards othersPLoS One2010512e1533721179515
   PubMed Web of Science ®Google Scholar
• HealyDAldredGAntidepressant drug use and the risk of suicideInt Rev Psychiatry200517316317216194787
   PubMed Web of Science ®Google Scholar
• Cem AtbaşogluESchultzSKAndreasenNCThe relationship of akathisia with suicidality and depersonalization among patients with schizophreniaJ Neuropsychiatry Clin Neurosci200113333634111514639
   PubMed Web of Science ®Google Scholar
• ShearMKFrancesAWeidenPSuicide associated with akathisia and depot fluphenazine treatmentJ Clin Psychopharmacol1983342352366886035
   PubMed Web of Science ®Google Scholar
• SchulteJLHomicide and suicide associated with akathisia and haloperidolAm J Forensic Psychiatry19856237
   Google Scholar
• HealyDHerxheimerAMenkesDBAntidepressants and violence: problems at the interface of medicine and lawPLoS Med200639e37216968128
   PubMed Web of Science ®Google Scholar
• SSRI Stories: antidepressant nightmares [website on the Internet]. Available from: http://www.ssristories.com. Accessed April 12, 2011
   Google Scholar
• NewmanMBitter pills for drug companiesBMJ2010341c509520851842
   PubMed Web of Science ®Google Scholar
• HealyDManufacturing consensusCult Med Psychiatry200630213515616804639
   PubMed Web of Science ®Google Scholar
• Regina v Hawkins [2001] NSWSC 420, 2001
   Google Scholar
• Cassidy v Eli Lilly and Company, 2002, Civil Action No. 821, United States District Court for the Western District of Pennsylvania. Available from: http://www.prozactruth.com/genetictesting.htm. Accessed April 29, 2011
   Google Scholar
• HealyDLet them eat Prozac [homepage on the Internet]. [Nd.] Available from: http://www.healyprozac.com. Accessed July 1, 2011
   Google Scholar
• Innocence Project [homepage on the Internet]New York, NY nd. http://www.innocenceproject.org. Accessed June 13, 2011
   Google Scholar
• WongSHHappyCBlinkaDFrom personalized medicine to personalized justice: the promises of translational pharmacogenomics in the justice systemPharmacogenomics201011673173720504247
   PubMed Web of Science ®Google Scholar
• PigottHELeventhalAMAlterGSBorenJJEfficacy and effectiveness of antidepressants: current status of researchPsychother Psychosom201079526727920616621
   PubMed Web of Science ®Google Scholar